Itron (ITRI) Cash & Equivalents (2009 - 2026)

Itron (ITRI) has 18 years of Cash & Equivalents data on file, last reported at $745.2 million in Q2 2026.

• Quarterly Cash & Equivalents fell 39.13% year-over-year to $745.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $745.2 million (down 39.13% YoY) and the FY2025 annual result came in at $1.0 billion, down 2.93% from the prior year.
• Cash & Equivalents improved to $745.2 million in Q2 2026, from $712.8 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $1.3 billion in Q3 2025 to a low of $196.0 million in Q1 2023.
• A 5-year average of $623.8 million and a median of $507.4 million in 2023 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents tumbled 64.5% — and 2024, when it jumped 295.49%.
• Tracing ITRI's Cash & Equivalents over 5 years: stood at $202.0 million in 2022, then jumped by 49.52% to $302.0 million in 2023, then soared by 248.04% to $1.1 billion in 2024, then declined by 2.93% to $1.0 billion in 2025, then declined by 26.97% to $745.2 million in 2026.
• The last three Cash & Equivalents figures came in at $745.2 million (Q2 2026), $712.8 million (Q1 2026), and $1.0 billion (Q4 2025), per Business Quant data.